Population‐based study revealed increased risks of basal cell carcinoma (22%) and squamous cell carcinoma (88%) in patients with rheumatoid arthritis not receiving biologic agents, with additional risks observed in those treated with TNF inhibitors [33]. This evidence concerns the gene TNF and basal cell carcinoma.